Perrigo | PRGO - Current Assets


Perrigo reported $2.45B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
Abbott USD 25.51B 488M Mar/2026
Bayer EUR 33.64B 1.66B Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Coherus Biosciences USD 133.79M 72.25M Jun/2026
Corcept Therapeutics USD 439.68M 13.64M Jun/2026
Dr.Reddys Laboratories INR 299.33B 2.46B Jun/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
J&J USD 59.77B 601M Jun/2026
Merck USD 36.68B 1.66B Jun/2026
Nestle CHF 37.58B 5.61B Jun/2026
Pacira USD 615.21M 100.25M Jun/2026
Perrigo USD 2.45B 260.7M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Prestige Brands USD 496.81M 65.33M Jun/2026
Reckitt Benckiser GBP 4.6B 287M Dec/2024
Sanofi EUR 31.52B 1.36B Jun/2026
Supernus Pharmaceuticals USD 723.5M 8.08M Jun/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026
Xeris Pharmaceuticals USD 274.76M 23.08M Jun/2026
Zoetis USD 6.36B 118M Jun/2026